Ligand Pharmaceuticals Inc
XBER:LGDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Ligand Pharmaceuticals Inc
XBER:LGDN
|
US |
Wall St Price Targets
LGDN Price Targets Summary
Ligand Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for LGDN is 216.27 EUR with a low forecast of 175.29 EUR and a high forecast of 273.35 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LGDN's stock price target?
Price Target
216.27
EUR
According to Wall Street analysts, the average 1-year price target for LGDN is 216.27 EUR with a low forecast of 175.29 EUR and a high forecast of 273.35 EUR.
What is the Revenue forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 13%.
What is the Operating Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
29%
Over the last 14 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 8 years is 29%.
What is the Net Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 7 years is 17%.
